The high-profile case has been referred to the ICAI's FRRB or Financial Reporting Review Board and adds that more clarity is required on fraud reporting by auditors to the government, says K Raghu. Bain Capital's move to sue EY in a US court over a $60 ... Economic Times, 1 month ago
SEBI's Board announced new norms for public shareholding for all listed companies including PSUs, ESOP scheme, offer for sale -OFS mechanism as well as research analysts Market regulator Securities and Exchange Board of India (SEBI) on Thursday ...Money Life, 1 month ago
Cellectis and Accelera (Nerviano Medical Sciences Group) Sign an Agreement to Complete Preclinical Studies of Cellectis' Lead Product Candidate UCART19
Cellectis (Paris:ALCLS), a leader of allogeneic CAR T-cell therapies, and Accelera, the preclinical CRO (Contract Research Organisation) within the Nerviano Medical Sciences Group, recently signed an agreement to complete the preclinical studies of ...Fierce CRO, 1 month ago Cellectis et Accelera (Groupe Nerviano Medical Sciences) signent un accord pour réaliser les études précliniques de UCART19, le produit phare de Cellectis Business Wire, 1 month ago
on your WebpageAdd Widget >Get your members hooked!